10 Results for "

hormone-independent

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "hormone-independent" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N0539
CAS No.: 105471-98-5
Calceolarioside B is a phenylethanoid glycoside. Calceolarioside B can be isolated from the leaves of Akebia quinata. Calceolarioside B inhibits RLAR activity with an IC50 value of 23.99 μM. Calceolarioside B inhibits the entry of Omicron BA.2 into host cells. Calceolarioside B reduces IL-6 levels. Calceolarioside B has immunomodulatory activity. Calceolarioside B has anticancer activity against human hormone-independent prostate cancer .
loading...
    loading...
Cat. No.: HY-145709
CAS No.: 2230880-25-6
Purity:  98.02%
Target:  

Androgen Receptor

Research Areas:  

Cancer

Ar-V7-IN-1 is a potent inhibitor of Ar-V7. Ar-V7-IN-1 inhibits the transcriptional activity of androgen receptor (AR) and the secretion of prostate-specific antigen (PSA) with an eGFP IC50 of 1232 nM and the PSA IC50 of 1391 μM. Ar-V7-IN-1 has the potential for the research of various indications, in particular cancers such as prostate cancer .
loading...
    loading...
Cat. No.: HY-110201
CAS No.: 63676-22-2
Purity:  99.91%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Estrogen receptor modulator 1 (compound 18) is an orally active and selective estrogen receptor modulator (SERM), with a pIC50 of 0.46. Estrogen receptor modulator 1 induces regression of Tamoxifen-resistant, hormone independent xenograft tumors .
loading...
    loading...
Cat. No.: HY-106058
CAS No.: 84518-80-9
Target:  

Cathepsin Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

NCO-700 is a dual cathepsin B and calcium-activated neutral protease (CANP) inhibitor with IC50 values of 0.8 and 46 μM, respectively. NCO-700 reduces the degradation of myocardial fibrin by inhibiting protease activity. NCO-700 also has inhibitory effects on hormone-independent tumor cells, such as prostate cancer cells, and induces apoptosis. NCO-700 can be used to study myocardial ischemia and refractory hormone-independent tumors .
loading...
    loading...
Cat. No.: HY-133222
CAS No.: 401600-86-0
Research Areas:  

Cancer

STX140 is an orally active microtubule disruptor. STX140 induces apoptosis in the hormone-independent PC-3 prostate cell lines. STX140 has anti-angiogenic and anti-tumour activities .
loading...
    loading...
Cat. No.: HY-N0539R
CAS No.: 105471-98-5
Calceolarioside B (Standard) is the analytical standard of Calceolarioside B (HY-N0539). This product is intended for research and analytical applications. Calceolarioside B is a phenylethanoid glycoside. Calceolarioside B can be isolated from the leaves of Akebia quinata. Calceolarioside B inhibits RLAR activity with an IC50 value of 23.99 μM. Calceolarioside B inhibits the entry of Omicron BA.2 into host cells. Calceolarioside B reduces IL-6 levels. Calceolarioside B has immunomodulatory activity. Calceolarioside B has anticancer activity against human hormone-independent prostate cancer .
loading...
    loading...
Cat. No.: HY-149486
Target:  

FGFR

Research Areas:  

Cancer

FGFR1 inhibitor 7 (compound 5) is an inhibitor of FGFR1 Tyrosine Kinase with IC50 value of 0.33 nM. FGFR1 inhibitor 7 shows broad-spectrum cytotoxicity agasinst human cancer cell lines, and inhibits MOLT3 cells with IC50 of 2.1 μM .
loading...
    loading...
Cat. No.: HY-106058A
CAS No.: 84579-82-8
Target:  

Cathepsin Apoptosis

Research Areas:  

Cancer

NCO-700 sulfate is a dual cathepsin B and calcium-activated neutral protease (CANP) inhibitor with IC50 values of 0.8 and 46 μM, respectively. NCO-700 sulfate reduces the degradation of myocardial fibrin by inhibiting protease activity. NCO-700 sulfate also has inhibitory effects on hormone-independent tumor cells, such as prostate cancer cells, and induces apoptosis. NCO-700 sulfate can be used to study myocardial ischemia and refractory hormone-independent tumors .
loading...
    loading...
Cat. No.: HY-111015
CAS No.: 955082-09-4
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

IRC-083927 hydrochloride is an orally active tubulin inhibitor. IRC-083927 hydrochloride binds competitively to the colchicine-binding site on tubulin, inhibits tubulin polymerization, disrupts the microtubule cytoskeleton, and arrests the cell cycle at the G2-M phase. IRC-083927 hydrochloride can be used in research related to human cervical cancer, hormone-independent breast cancer, pancreatic cancer, prostate cancer, and small cell lung cancer .
loading...
    loading...
Cat. No.: HY-111015A
CAS No.: 955157-23-0
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

IRC-083927 is an orally active tubulin inhibitor. IRC-083927 binds competitively to the colchicine-binding site on tubulin, inhibits tubulin polymerization, disrupts the microtubule cytoskeleton, and arrests the cell cycle at the G2-M phase. IRC-083927 can be used in research related to human cervical cancer, hormone-independent breast cancer, pancreatic cancer, prostate cancer, and small cell lung cancer .
loading...
    loading...